Symyx Announces Collaborative Partnership with Royal Society of Chemistry
News Dec 30, 2009
Symyx Technologies, Inc. and the Royal Society of Chemistry (RSC) have announced the launch of a collaborative partnership designed to enhance the usability and accessibility of public scientific databases.
The first joint project links related chemical structures between two information sources, ChemSpider (from RSC) and DiscoveryGate (from Symyx), enabling scientists to retrieve more complete and comprehensive information.
ChemSpider is a free-access chemistry search engine that aggregates and indexes chemical structures and their associated information into a single searchable repository.
DiscoveryGate provides online access to chemical sourcing, organic synthesis and reaction planning, metabolism, toxicity and pharmacological information, integrating information based on the occurrence of common chemical structures.
Interlinking the two products will enable scientists to browse chemical information on ChemSpider while simultaneously searching synthetic reactions, bioavailability information and up-to-date compound availability information from over 860 suppliers on DiscoveryGate.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE